G Leonard Baker Jr bought $3.3M of Corcept Therapeutics Incorporated (CORT)
Executed Mar 17, disclosed Mar 19, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Mar 19), the stock returned +40.1% (delay-adjusted); from the execution session (Mar 17), +35.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
G Leonard Baker Jr (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Corcept Therapeutics Incorporated (CORT). Across 1 priced purchase filing, the average 21-session return was +35.5% from execution and +40.1% from disclosure (delay-adjusted; derived). The largest single filing was $3.3M of CORT (100,000 sh across 2 lots, as filed), executed Mar 17.
Healthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→